Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma
about
Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma.Expression of YKL-40 and MIP-1a proteins in exudates and transudates: biomarkers for differential diagnosis of pleural effusions? A pilot study.Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma.Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome Sequencing.Role of chitinase-like proteins in cancer.Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma.Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible?Potential suppressive effects of theophylline on human rectal cancer SW480 cells in vitro by inhibiting YKL-40 expression.Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications
P2860
Q33728232-3DEF7D24-C058-4B9B-A0DA-4DEB1DF63A04Q35856182-7F764AF1-5ECC-4ED2-AA3F-3B68DEED1C90Q36243433-9433713C-7372-4768-B25B-942B1DC6588FQ37118144-BDA8AD70-9B65-47CE-B611-25458EE61869Q38619003-A2A94669-0E4D-4BC7-BB61-7F9B6D1FFB23Q38687563-16FE4474-B843-4A67-835F-244565D7B0F4Q41392169-985AE13D-B468-4F32-9300-32B183B617A5Q47096302-FBA8B143-0419-46CF-9E16-800D8F7F4A30Q47253661-8AD9707B-3187-4B3D-B5D1-F347D0BB0C7CQ47325932-652C10FB-784C-48F8-AF6F-4A7C30609CF6Q47590477-A46332CF-7293-4F9C-A209-2B292C4082D5Q53105672-4CC27D00-70CC-4159-AEC8-8423D6C63ACAQ53527300-2345EDBF-FE7E-4D0E-9E7B-5C3AD603B320Q55210960-6A4BCA38-47EA-4D97-BAE6-8A6538D53A8FQ58732829-F5450BC0-F847-4652-88AA-9D4545C02FF9
P2860
Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Establishment of using serum Y ...... hageal squamous cell carcinoma
@ast
Establishment of using serum Y ...... hageal squamous cell carcinoma
@en
type
label
Establishment of using serum Y ...... hageal squamous cell carcinoma
@ast
Establishment of using serum Y ...... hageal squamous cell carcinoma
@en
prefLabel
Establishment of using serum Y ...... hageal squamous cell carcinoma
@ast
Establishment of using serum Y ...... hageal squamous cell carcinoma
@en
P2093
P2860
P356
P1433
P1476
Establishment of using serum Y ...... hageal squamous cell carcinoma
@en
P2093
Pei-Dong Chi
Qian Zhong
Shu-Qin Dai
Wan-Li Liu
Xiao-Min Liu
P2860
P2888
P356
10.1186/1471-2407-14-490
P407
P577
2014-07-07T00:00:00Z
P5875
P6179
1049218535